Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Current Oncology (Toronto, Ont.)|June 20, 2015
Using proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experienceE Baxter, L Gondara, C Lohrisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancersM J MacKenzie, H W Hirte, L L Siu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancerK A Gelmon, A Tolcher, S O'Reilly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2009
Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective studyR Yerushalmi, M R Kramer, S Rizel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancerN Murray, C Grafton, A Shah, et al.
Annals of Hematology|August 7, 2015
Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatmentFelicitas Hitz, J M Connors, R D Gascoyne, et al.
British Journal of Cancer|September 2, 1999
Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancerD G Bebb, Z Yu, J Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1992
Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neck cancerD Osoba, P R Band, J H Goldie, et al.
Pageof 5